| Q32 BIO INC. O.N. |
| USA |
| Gesundheit |
| US7469641051 / A4ZZ0Z |
| DB0 (Frankfurt) / QTTB (NASDAQ) |
| FRA:DB0, ETR:DB0, DB0:GR, NASDAQ:QTTB |
| - |
| https://www.q32bio.com/ |
|
Q32 Bio Inc. is a clinical-stage biotechnology company developing biologic therapeutics that target potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. Its primary focus is on be..
>Volltext.. |
| 92.17 Mio. EUR |
| 63.53 Mio. EUR |
| 46.7 Mio. EUR |
| 15.03 Mio. EUR |
| 25.91 Mio. EUR |
| 2.01 EUR |
| 13.33 Mio. EUR |
| 41.97 Mio. EUR |
| -29.15 Mio. EUR |
| 4.26 |
| - |
| - |
| - |
| - |
| - |
| - |
| Q32 BIO |
| 31.03.26 |
|